RGCC Test: What is it, and what does it tell you?
Many have heard of the RGCC test (also known as the Greece test), but few know exactly what to do once they get their results back.
For those that don’t know, according to its creator, Dr. Ioannis Papasotiriou, the ‘Greece’ test measures circulating tumor cell count in the blood stream. Circulating tumor cells (CTCs), as well as cancer stem cells (CSCs), are important because they are responsible for the metastasis of cancer. Both are also responsible for cancer returning.
The Greece test is supposedly useful because with only about 2 tablespoons of blood, natural anti-cancer as well as chemotherapeutic agents can be tested for effectiveness in combating CTCs and CSCs. The benefit here would huge for patients, as the testing is done in a lab, as opposed to the patient’s blood stream.
The RGCC test is also said to allow for a much more controlled environment than testing on a live patient – variables can be eliminated or accounted for, and multiple cancer-fighting agents can be tested in parallel (at the same time). This saves the patient vital time when combating cancer.
‘Greece’ Test Criticism
Criticisms for the test arise from the fact that many critics have stated that the time the test takes is not sufficient to test the amount of circulating tumor cells the test is said to extract. Additionally, blood tests can only detect tumor cells for blood-borne cancers, or cancers that have metastasized to the bloodstream.
These criticisms aside, many cancer patients choose to undergo the RGCC test. We chose to write this article because we hear from clients who undergo this test and hear some of their results, and we are often asked by potential clients how Haelan 951 could help them. Here’s what we know:
What The RGCC Test Looks for: Caspase Activation (Which Induces Cancer Cell Death)
While we cannot attest to the testing methodology of the ‘Greece’ test (this process is said to be patented but cannot currently be found by our staff), it is a fact that caspase activation is vital to reducing circulating tumor cells and cancer stem cells.
To get a little further into the details we need to start with apoptosis, which is the natural, healthy, programmed death of cells. In cancer patients, malignant cancer cells evade this process. By evading this process, these cancer cells bypass cell checkpoints and can resist cytotoxic agents that are designed to kill them (e.g. chemotherapy).
Apoptosis – natural cell death – is induced by the caspase pathway, a family of enzymes responsible for signalling cell death and reducing cellular inflammation.
How Does the RGCC Test Find Which Agents Induce Caspase Activation/Apoptosis?
According to their own literature, the Greece test leaves patient cancer cells in contact with the agent to be tested for a period of no less than 48 hours, after which cancer cell death is calculated. Again, the details of this process are cloudy – most likely for technology protection purposes.
Our Experience With Apoptosis and Cancer Cell Death, and What We Can Tell You About it
Apoptosis and cancer cell death is one of our primary areas of research, and was one of the founding goals of the company when it was formed 28 years ago. Since then, our research has been printed in thousands of leading journals and publications, and our flagship product, Haelan 951, has been widely studied and shown to induce apoptosis and cancer cell death by multiple third party studies. For this article in particular, we would point to the study: “The flavonoid beverage Haelan 951 induces growth arrest and apoptosis in pancreatic carcinoma cell lines in vitro” at the National Institute of Health website.
If you would like more information on the anti-cancer properties of Haelan 951 that can be tested with the RGCC test, have questions about starting Haelan 951, or would like access to our free library or research, please feel free to contact us or call (866) 360-2193.
The RGCC test has had some criticism and with a better understanding of the methodology we may be able to make a better assessment to their claims. While some believe the claims to be unsubstantiated we are unsure. However, of the many compounds tested, on the RGCC test, we are quite often contacted for our unparalleled levels of genistein. This has proven time and time again to be very anti-cancerous. Not only does Haelan 951 contain genistein but it contains the needed complimentary compounds to assimilate it.
We believe that cancer patients and their families are best served by taking a multi-faceted, proactive role in their treatment, and thus we applaud searching out new techniques and treatments. Although we cannot fully endorse the RGCC test until we better understand their testing methodology, we have had many clients see great results from implementing what the testing results show.
Haelan 951 is a specialized nutritional concentrate for patients undergoing chemotherapy and radiation treatment. Many patients see their costs covered by insurance and it is available either through prescription or direct order.